Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 276, Issue 2 20-2, 1999, Pages

  Reeve, Helen L ^a,b,e   Nelson, Daniel P ^c   Archer, Stephen L ^d   Weir, E Kenneth ^b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e VA MEDICAL CENTER   (United States)

Author keywords

Anorexic; Membrane potential; Potassium channels; Pulmonary hypertension; Serotonin

Indexed keywords

DEXFENFLURAMINE; FLUOXETINE; PHENTERMINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTERIAL PRESSURE; ARTICLE; DRUG POTENCY; LUNG ARTERY PRESSURE; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RISK ASSESSMENT; SEROTONIN RELEASE; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; VASOCONSTRICTION;

EID: 0033053965     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.276.2.l213     Document Type: Article

References (34)

1. Abenhaim, L., Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, T. Higgenbottom, C. Oakley, E. Wouters, M. Aubier, G. Simonneau, and B. Begaud. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N. Engl. J. Med. 335: 609-616, 1996.
2. Anchors, M. Safer Than Fen-Phen. Rocklin, CA: Prima Publishing, 1997.
3. Archer, S. L., K. Djaballah, M. Humbert, E. K. Weir, M. Fartoukh, J. Dall'Ava-Santucci, J.-C. Mercier, G. Simmonneau, and A. T. Dinh-Xuan. Nitric oxide deficiency in pulmonary hypertension associated with the anorectic agents fenfluramine and dexfenfluramine. Am. J. Respir. Crit. Care Med. 158: 1061-1067, 1998.
4. 2 sensor in rat pulmonary vasculature. Circ. Res. 73: 1100-1112, 1993.
5. Archer, S. L., J. M. C. Huang, H. L. Reeve, V. Hampl, S. Tolarova, E. Michelakis, and E. K. Weir. The differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ. Res. 78: 431-442, 1996.
6. + channels, Kv1.5 and 2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potentials in rat arterial myocytes. J. Clin. Invest. 10: 1-12, 1998.
7. Brenot, F., P. Herve, P. Petitpretz, F. Parent, P. Duroux, and G. Simonneau. Primary pulmonary hypertension and fenfluramine use. Br. Heart J. 70: 537-541, 1993.
8. Connolly, H., J. Crary, M. McGoon, D. Hensrud, B. Edwards, W. Edwards, and H. Schaff. Valvular heart disease is associated with fenfluramine-phentermine. N. Engl. J. Med. 337: 581-588, 1997.
9. D'Alonzo, G. E., R. J. Barst, and S. M. Ayres. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann. Intern. Med. 115: 343-349, 1991.
10. Dunne, M., C. Kane, R. Shepherd, and J. Sanchez. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N. Engl. J. Med. 336: 703-706, 1997.
11. Farrugia, G. Modulation of ionic currents in isolated canine and human jejunal circular smooth muscle cells by fluoxetine. Gastroenterology 110: 1438-1445, 1996.
12. Frishman, W. H., S. Huberfield, S. Okin, Y. Wang, A. Kumar, and B. Shareef. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. J. Clin. Pharmacol. 35: 541-572, 1995.
13. Gurtner, H. Atiologie and haufigkeit der primer vaskularen formen des chronischen cor pulmonale. Dtsch. Med. Wochenschr. 94: 850-852, 1969.
14. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high resolution recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-89, 1981.
15. Herve, P., J.-M. Launay, M.-L. Scrobohaci, F. Brenot, G. Simonneau, P. Petitpretz, P. Poubeau, J. Cerrina, P. Duroux, and L. Drouet. Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med. 99: 249-254, 1995.
16. Hevers, W., and R. C. Hardie. Serotonin modulates the voltage-dependence of delayed rectifier and Shaker potassium channels in Drosophila photoreceptors. Neuron 14: 845-856, 1995.
17. Holliday, S. M., and P. Benfield. Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs 49: 280-294, 1995.
18. Kane, C., R. Shepherd, P. Squires, P. Johnson, R. James, P. Milla, A. Aynsley-Green, K. Lindley, and M. Dunne. Loss of functional KATP channels in β cells causes persistent hyperinsulinaemic hypoglycemia of infancy. Nat. Med. 2: 1344-1347, 1996.
19. McGinnis, J., and W. Foege. Actual causes of death in the United States. JAMA 270: 2207-2212, 1994.
20. McGoon, M., and P. Vanhoutte. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J. Clin. Invest. 74: 823-833, 1984.
21. McTavish, D., and R. Heel. Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. Drugs 43: 713-733, 1992.
22. Mlczoch, J. Drug and dietary induced pulmonary hypertension. In: Pulmonary Hypertension, edited by E. K. Weir and J. T. Reeves. New York: Futura, 1984, p. 341-359.
23. Neely, C., D. Haile, and I. Matot. Tone-dependent responses of 5-hydroxytryptamine in the feline pulmonary vascular bed are mediated by two different 5-hydroxytryptamine receptors. J. Pharmacol. Exp. Ther. 264: 1315-1326, 1993.
24. + membrane channels. Brain Res. 1: 31-38, 1990.
25. + channel in oxygen-sensitive pulmonary artery myocytes. EMBO J. 16: 6615-6625, 1997.
26. Rae, J., K. Cooper, G. Gates, and M. Watsky. Low access resistance perforated patch recordings using amphotericin B. J. Neurosci. Methods 37: 15-26, 1991.
27. Silverstone, T. Appetite suppressants. Drugs 43: 820-836, 1992.
28. Stark, P., R. Fuller, and D. Wong. The pharmacological profile of fluoxetine. J. Clin. Psychiatry 46: 7-13, 1985.
29. + channel α subunits in pulmonary artery smooth muscle cells. J. Clin. Invest. 9: 2347-2353, 1997.
30. Weir, E. K., and S. L. Archer. The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. FASEB J. 9: 183-189, 1995.
31. Weir, E. K., H. L. Reeve, J. Huang, E. Michelakis, D. Nelson, V. Hampl, and S. L. Archer. Anorexic agents aminorex, fenfluramine and dexfenfluramine inhibit potassium current in rat vascular smooth muscle and cause pulmonary vasoconstriction. Circulation 94: 2216-2220, 1996.
32. Wong, D., F. Bymaster, and E. Engleman. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57: 411-441, 1995.
33. i in pulmonary arterial myocytes. Circ. Res. 77: 370-378, 1995.
34. + channel gene transcription in primary pulmonary hypertension. Lancet 351: 726-727, 1998.